Skip to main content
Filing year 2024

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC

Brooklyn, New York·EIN 11-3106037·NTEE G20 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$483k
Total assets
$67k
Total expenses
$483k
Reported officers
2
Mission

To improve the quality of life for individuals and families living with sickle cell disease, and other inherited blood disorders.

Reported officers (all unpaid)

No paid executives reported in 2024. SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC reported 2 unpaid officers and board members on its 990.

President
Secretary
Financial trend

Revenue and expenses over time

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC reported revenue and expenses across 3 filing years.

RevenueExpenses
$421k
$484k
2022
$262k
$250k
2023
$483k
$483k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn in New York

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization in New York earns a median of $133,355.

25th percentile
$56k
Median
$133,355
75th percentile
$271k
90th percentile
$406k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 204 organizations across 204 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines pay data for New York →
FAQ

Common questions about SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC

What are SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC's revenue and expenses?

In 2024, SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC reported $483k in total revenue and $483k in total expenses on its IRS Form 990.

Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.